Loading…
Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer
BACKGROUND The association between serum sex steroid hormones and PSA in a general population has not been described. METHODS Included were 378 men aged 40–85 years who participated in the National Health and Nutrition Examination Survey in 2001–2004, who did not have a prostate cancer diagnosis, an...
Saved in:
Published in: | The Prostate 2015-08, Vol.75 (11), p.1167-1176 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5568-6bda139d14e27e69c5f5c625f17b93c0ccad9c65a004350da7fd361c128190113 |
---|---|
cites | cdi_FETCH-LOGICAL-c5568-6bda139d14e27e69c5f5c625f17b93c0ccad9c65a004350da7fd361c128190113 |
container_end_page | 1176 |
container_issue | 11 |
container_start_page | 1167 |
container_title | The Prostate |
container_volume | 75 |
creator | Peskoe, Sarah B. Joshu, Corinne E. Rohrmann, Sabine McGlynn, Katherine A. Nyante, Sarah J. Bradwin, Gary Dobs, Adrian S. Kanarek, Norma Nelson, William G. Platz, Elizabeth A. |
description | BACKGROUND
The association between serum sex steroid hormones and PSA in a general population has not been described.
METHODS
Included were 378 men aged 40–85 years who participated in the National Health and Nutrition Examination Survey in 2001–2004, who did not have a prostate cancer diagnosis, and had not had a recent biopsy, rectal examination, cystoscopy, or prostate infection or inflammation. Serum total PSA, total testosterone, androstanediol glucuronide (3α‐diol‐G), estradiol, and sex hormone binding globulin (SHBG) concentrations were previously measured. Free testosterone was estimated by mass action. We applied sampling weights and calculated geometric mean PSA concentration by hormone quintiles adjusting for age and race/ethnicity, and also for body mass index, waist circumference, smoking, diabetes, and mutually for hormones. We estimated the OR of PSA ≥2.5 ng/ml per hormone quintile using logistic regression.
RESULTS
Geometric mean PSA increased across testosterone quintiles after age and race/ethnicity (Q1: 0.80, Q5: 1.14 ng/ml; P‐trend = 0.002) and multivariable (Q1: 0.79, Q5: 1.16 ng/ml; P‐trend = 0.02) adjustment; patterns were similar for free testosterone and 3α‐diol‐G. SHBG was inversely associated with PSA only after multivariable adjustment (Q1: 1.32, Q5: 0.82 nmol/L; P‐trend = 0.01). Estradiol and PSA were not associated. The OR of PSA ≥2.5 ng/ml was 1.54 (95%CI 1.18–2.01) per testosterone quintile after age and race/ethnicity adjustment, and 1.78 (95%CI 1.16–2.73) after multivariable adjustment.
CONCLUSIONS
In this nationally representative sample, men with higher testosterone had higher PSA even after taking into account other hormones and modifiable factors. Men with higher SHBG had lower PSA, but only after multivariable adjustment. Prostate 75: 1167–1176, 2015. © 2015 Wiley Periodicals, Inc. |
doi_str_mv | 10.1002/pros.22998 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4475411</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1690216498</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5568-6bda139d14e27e69c5f5c625f17b93c0ccad9c65a004350da7fd361c128190113</originalsourceid><addsrcrecordid>eNp9kcFu1DAYhCMEotvChQdAlrigSim2E9vxBalaQUCsaMWCerS8jrN1cexgJy37CLw1zqZdAQdOlv1__2g8k2UvEDxDEOI3ffDxDGPOq0fZAkHOcghL8jhbQMxgXqKCHWXHMd5AmHCIn2ZHmHDES4YW2a-lCWq0cjBuCwY_SAsGHQcfBx2800C6Blyuz4HyTmk3hAR6F4FxQAK3v0hrdyDoPuiYgPR0q0GUXW818C3otAN3Zrj245A2GiO3zkcTp9FkO_EaKJm0w7PsSStt1M_vz5Ps2_t3X5cf8tVF_XF5vsoVIbTK6aaRqOANKjVmmnJFWqIoJi1iG14oqJRsuKJEpgwKAhvJ2qagSCFcIQ4RKk6yt7NuP2463cy_sqIPppNhJ7w04u-JM9di629FWTJS7gVe3wsE_2NMYYnORKWtlU77MQpEOcSIlrxK6Kt_0Bs_hhTZRFWcMs4ZT9TpTKmUSAy6PZhBUEwNiykqsW84wS__tH9AHypNAJqBO2P17j9S4vLLxfpBNJ93TOr952FHhu-CsoIRcfW5Fp-u1nVdrWrBi9-XNcQg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1689679979</pqid></control><display><type>article</type><title>Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Peskoe, Sarah B. ; Joshu, Corinne E. ; Rohrmann, Sabine ; McGlynn, Katherine A. ; Nyante, Sarah J. ; Bradwin, Gary ; Dobs, Adrian S. ; Kanarek, Norma ; Nelson, William G. ; Platz, Elizabeth A.</creator><creatorcontrib>Peskoe, Sarah B. ; Joshu, Corinne E. ; Rohrmann, Sabine ; McGlynn, Katherine A. ; Nyante, Sarah J. ; Bradwin, Gary ; Dobs, Adrian S. ; Kanarek, Norma ; Nelson, William G. ; Platz, Elizabeth A.</creatorcontrib><description>BACKGROUND
The association between serum sex steroid hormones and PSA in a general population has not been described.
METHODS
Included were 378 men aged 40–85 years who participated in the National Health and Nutrition Examination Survey in 2001–2004, who did not have a prostate cancer diagnosis, and had not had a recent biopsy, rectal examination, cystoscopy, or prostate infection or inflammation. Serum total PSA, total testosterone, androstanediol glucuronide (3α‐diol‐G), estradiol, and sex hormone binding globulin (SHBG) concentrations were previously measured. Free testosterone was estimated by mass action. We applied sampling weights and calculated geometric mean PSA concentration by hormone quintiles adjusting for age and race/ethnicity, and also for body mass index, waist circumference, smoking, diabetes, and mutually for hormones. We estimated the OR of PSA ≥2.5 ng/ml per hormone quintile using logistic regression.
RESULTS
Geometric mean PSA increased across testosterone quintiles after age and race/ethnicity (Q1: 0.80, Q5: 1.14 ng/ml; P‐trend = 0.002) and multivariable (Q1: 0.79, Q5: 1.16 ng/ml; P‐trend = 0.02) adjustment; patterns were similar for free testosterone and 3α‐diol‐G. SHBG was inversely associated with PSA only after multivariable adjustment (Q1: 1.32, Q5: 0.82 nmol/L; P‐trend = 0.01). Estradiol and PSA were not associated. The OR of PSA ≥2.5 ng/ml was 1.54 (95%CI 1.18–2.01) per testosterone quintile after age and race/ethnicity adjustment, and 1.78 (95%CI 1.16–2.73) after multivariable adjustment.
CONCLUSIONS
In this nationally representative sample, men with higher testosterone had higher PSA even after taking into account other hormones and modifiable factors. Men with higher SHBG had lower PSA, but only after multivariable adjustment. Prostate 75: 1167–1176, 2015. © 2015 Wiley Periodicals, Inc.</description><identifier>ISSN: 0270-4137</identifier><identifier>EISSN: 1097-0045</identifier><identifier>DOI: 10.1002/pros.22998</identifier><identifier>PMID: 25919471</identifier><identifier>CODEN: PRSTDS</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Androstane-3,17-diol - analogs & derivatives ; Androstane-3,17-diol - blood ; Body Mass Index ; Effect Modifier, Epidemiologic ; Estradiol - blood ; Ethnic Groups ; Ethnicity ; Hormones ; Humans ; Logistic Models ; Male ; men ; Nutrition Surveys ; Prostate cancer ; prostate specific antigen ; Prostate-Specific Antigen - blood ; Sex Hormone-Binding Globulin - analysis ; Statistics as Topic ; Testosterone ; Testosterone - blood</subject><ispartof>The Prostate, 2015-08, Vol.75 (11), p.1167-1176</ispartof><rights>2015 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5568-6bda139d14e27e69c5f5c625f17b93c0ccad9c65a004350da7fd361c128190113</citedby><cites>FETCH-LOGICAL-c5568-6bda139d14e27e69c5f5c625f17b93c0ccad9c65a004350da7fd361c128190113</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25919471$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peskoe, Sarah B.</creatorcontrib><creatorcontrib>Joshu, Corinne E.</creatorcontrib><creatorcontrib>Rohrmann, Sabine</creatorcontrib><creatorcontrib>McGlynn, Katherine A.</creatorcontrib><creatorcontrib>Nyante, Sarah J.</creatorcontrib><creatorcontrib>Bradwin, Gary</creatorcontrib><creatorcontrib>Dobs, Adrian S.</creatorcontrib><creatorcontrib>Kanarek, Norma</creatorcontrib><creatorcontrib>Nelson, William G.</creatorcontrib><creatorcontrib>Platz, Elizabeth A.</creatorcontrib><title>Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer</title><title>The Prostate</title><addtitle>Prostate</addtitle><description>BACKGROUND
The association between serum sex steroid hormones and PSA in a general population has not been described.
METHODS
Included were 378 men aged 40–85 years who participated in the National Health and Nutrition Examination Survey in 2001–2004, who did not have a prostate cancer diagnosis, and had not had a recent biopsy, rectal examination, cystoscopy, or prostate infection or inflammation. Serum total PSA, total testosterone, androstanediol glucuronide (3α‐diol‐G), estradiol, and sex hormone binding globulin (SHBG) concentrations were previously measured. Free testosterone was estimated by mass action. We applied sampling weights and calculated geometric mean PSA concentration by hormone quintiles adjusting for age and race/ethnicity, and also for body mass index, waist circumference, smoking, diabetes, and mutually for hormones. We estimated the OR of PSA ≥2.5 ng/ml per hormone quintile using logistic regression.
RESULTS
Geometric mean PSA increased across testosterone quintiles after age and race/ethnicity (Q1: 0.80, Q5: 1.14 ng/ml; P‐trend = 0.002) and multivariable (Q1: 0.79, Q5: 1.16 ng/ml; P‐trend = 0.02) adjustment; patterns were similar for free testosterone and 3α‐diol‐G. SHBG was inversely associated with PSA only after multivariable adjustment (Q1: 1.32, Q5: 0.82 nmol/L; P‐trend = 0.01). Estradiol and PSA were not associated. The OR of PSA ≥2.5 ng/ml was 1.54 (95%CI 1.18–2.01) per testosterone quintile after age and race/ethnicity adjustment, and 1.78 (95%CI 1.16–2.73) after multivariable adjustment.
CONCLUSIONS
In this nationally representative sample, men with higher testosterone had higher PSA even after taking into account other hormones and modifiable factors. Men with higher SHBG had lower PSA, but only after multivariable adjustment. Prostate 75: 1167–1176, 2015. © 2015 Wiley Periodicals, Inc.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Androstane-3,17-diol - analogs & derivatives</subject><subject>Androstane-3,17-diol - blood</subject><subject>Body Mass Index</subject><subject>Effect Modifier, Epidemiologic</subject><subject>Estradiol - blood</subject><subject>Ethnic Groups</subject><subject>Ethnicity</subject><subject>Hormones</subject><subject>Humans</subject><subject>Logistic Models</subject><subject>Male</subject><subject>men</subject><subject>Nutrition Surveys</subject><subject>Prostate cancer</subject><subject>prostate specific antigen</subject><subject>Prostate-Specific Antigen - blood</subject><subject>Sex Hormone-Binding Globulin - analysis</subject><subject>Statistics as Topic</subject><subject>Testosterone</subject><subject>Testosterone - blood</subject><issn>0270-4137</issn><issn>1097-0045</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp9kcFu1DAYhCMEotvChQdAlrigSim2E9vxBalaQUCsaMWCerS8jrN1cexgJy37CLw1zqZdAQdOlv1__2g8k2UvEDxDEOI3ffDxDGPOq0fZAkHOcghL8jhbQMxgXqKCHWXHMd5AmHCIn2ZHmHDES4YW2a-lCWq0cjBuCwY_SAsGHQcfBx2800C6Blyuz4HyTmk3hAR6F4FxQAK3v0hrdyDoPuiYgPR0q0GUXW818C3otAN3Zrj245A2GiO3zkcTp9FkO_EaKJm0w7PsSStt1M_vz5Ps2_t3X5cf8tVF_XF5vsoVIbTK6aaRqOANKjVmmnJFWqIoJi1iG14oqJRsuKJEpgwKAhvJ2qagSCFcIQ4RKk6yt7NuP2463cy_sqIPppNhJ7w04u-JM9di629FWTJS7gVe3wsE_2NMYYnORKWtlU77MQpEOcSIlrxK6Kt_0Bs_hhTZRFWcMs4ZT9TpTKmUSAy6PZhBUEwNiykqsW84wS__tH9AHypNAJqBO2P17j9S4vLLxfpBNJ93TOr952FHhu-CsoIRcfW5Fp-u1nVdrWrBi9-XNcQg</recordid><startdate>20150801</startdate><enddate>20150801</enddate><creator>Peskoe, Sarah B.</creator><creator>Joshu, Corinne E.</creator><creator>Rohrmann, Sabine</creator><creator>McGlynn, Katherine A.</creator><creator>Nyante, Sarah J.</creator><creator>Bradwin, Gary</creator><creator>Dobs, Adrian S.</creator><creator>Kanarek, Norma</creator><creator>Nelson, William G.</creator><creator>Platz, Elizabeth A.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TO</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150801</creationdate><title>Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer</title><author>Peskoe, Sarah B. ; Joshu, Corinne E. ; Rohrmann, Sabine ; McGlynn, Katherine A. ; Nyante, Sarah J. ; Bradwin, Gary ; Dobs, Adrian S. ; Kanarek, Norma ; Nelson, William G. ; Platz, Elizabeth A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5568-6bda139d14e27e69c5f5c625f17b93c0ccad9c65a004350da7fd361c128190113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Androstane-3,17-diol - analogs & derivatives</topic><topic>Androstane-3,17-diol - blood</topic><topic>Body Mass Index</topic><topic>Effect Modifier, Epidemiologic</topic><topic>Estradiol - blood</topic><topic>Ethnic Groups</topic><topic>Ethnicity</topic><topic>Hormones</topic><topic>Humans</topic><topic>Logistic Models</topic><topic>Male</topic><topic>men</topic><topic>Nutrition Surveys</topic><topic>Prostate cancer</topic><topic>prostate specific antigen</topic><topic>Prostate-Specific Antigen - blood</topic><topic>Sex Hormone-Binding Globulin - analysis</topic><topic>Statistics as Topic</topic><topic>Testosterone</topic><topic>Testosterone - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peskoe, Sarah B.</creatorcontrib><creatorcontrib>Joshu, Corinne E.</creatorcontrib><creatorcontrib>Rohrmann, Sabine</creatorcontrib><creatorcontrib>McGlynn, Katherine A.</creatorcontrib><creatorcontrib>Nyante, Sarah J.</creatorcontrib><creatorcontrib>Bradwin, Gary</creatorcontrib><creatorcontrib>Dobs, Adrian S.</creatorcontrib><creatorcontrib>Kanarek, Norma</creatorcontrib><creatorcontrib>Nelson, William G.</creatorcontrib><creatorcontrib>Platz, Elizabeth A.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Prostate</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peskoe, Sarah B.</au><au>Joshu, Corinne E.</au><au>Rohrmann, Sabine</au><au>McGlynn, Katherine A.</au><au>Nyante, Sarah J.</au><au>Bradwin, Gary</au><au>Dobs, Adrian S.</au><au>Kanarek, Norma</au><au>Nelson, William G.</au><au>Platz, Elizabeth A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer</atitle><jtitle>The Prostate</jtitle><addtitle>Prostate</addtitle><date>2015-08-01</date><risdate>2015</risdate><volume>75</volume><issue>11</issue><spage>1167</spage><epage>1176</epage><pages>1167-1176</pages><issn>0270-4137</issn><eissn>1097-0045</eissn><coden>PRSTDS</coden><abstract>BACKGROUND
The association between serum sex steroid hormones and PSA in a general population has not been described.
METHODS
Included were 378 men aged 40–85 years who participated in the National Health and Nutrition Examination Survey in 2001–2004, who did not have a prostate cancer diagnosis, and had not had a recent biopsy, rectal examination, cystoscopy, or prostate infection or inflammation. Serum total PSA, total testosterone, androstanediol glucuronide (3α‐diol‐G), estradiol, and sex hormone binding globulin (SHBG) concentrations were previously measured. Free testosterone was estimated by mass action. We applied sampling weights and calculated geometric mean PSA concentration by hormone quintiles adjusting for age and race/ethnicity, and also for body mass index, waist circumference, smoking, diabetes, and mutually for hormones. We estimated the OR of PSA ≥2.5 ng/ml per hormone quintile using logistic regression.
RESULTS
Geometric mean PSA increased across testosterone quintiles after age and race/ethnicity (Q1: 0.80, Q5: 1.14 ng/ml; P‐trend = 0.002) and multivariable (Q1: 0.79, Q5: 1.16 ng/ml; P‐trend = 0.02) adjustment; patterns were similar for free testosterone and 3α‐diol‐G. SHBG was inversely associated with PSA only after multivariable adjustment (Q1: 1.32, Q5: 0.82 nmol/L; P‐trend = 0.01). Estradiol and PSA were not associated. The OR of PSA ≥2.5 ng/ml was 1.54 (95%CI 1.18–2.01) per testosterone quintile after age and race/ethnicity adjustment, and 1.78 (95%CI 1.16–2.73) after multivariable adjustment.
CONCLUSIONS
In this nationally representative sample, men with higher testosterone had higher PSA even after taking into account other hormones and modifiable factors. Men with higher SHBG had lower PSA, but only after multivariable adjustment. Prostate 75: 1167–1176, 2015. © 2015 Wiley Periodicals, Inc.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>25919471</pmid><doi>10.1002/pros.22998</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0270-4137 |
ispartof | The Prostate, 2015-08, Vol.75 (11), p.1167-1176 |
issn | 0270-4137 1097-0045 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4475411 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Adult Aged Aged, 80 and over Androstane-3,17-diol - analogs & derivatives Androstane-3,17-diol - blood Body Mass Index Effect Modifier, Epidemiologic Estradiol - blood Ethnic Groups Ethnicity Hormones Humans Logistic Models Male men Nutrition Surveys Prostate cancer prostate specific antigen Prostate-Specific Antigen - blood Sex Hormone-Binding Globulin - analysis Statistics as Topic Testosterone Testosterone - blood |
title | Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T12%3A57%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Circulating%20total%20testosterone%20and%20PSA%20concentrations%20in%20a%20nationally%20representative%20sample%20of%20men%20without%20a%20diagnosis%20of%20prostate%20cancer&rft.jtitle=The%20Prostate&rft.au=Peskoe,%20Sarah%20B.&rft.date=2015-08-01&rft.volume=75&rft.issue=11&rft.spage=1167&rft.epage=1176&rft.pages=1167-1176&rft.issn=0270-4137&rft.eissn=1097-0045&rft.coden=PRSTDS&rft_id=info:doi/10.1002/pros.22998&rft_dat=%3Cproquest_pubme%3E1690216498%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5568-6bda139d14e27e69c5f5c625f17b93c0ccad9c65a004350da7fd361c128190113%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1689679979&rft_id=info:pmid/25919471&rfr_iscdi=true |